Patents/Assignees

SEATTLE CHILDREN'S RESEARCH INSTITUTE

4 patents in portfolio

US12378546utility2025
Coupling Endonucleases with End-processing Enzymes Drives High Efficiency Gene Disruption
0 cites
US12152079utility2024
Nucleic Acids Encoding IL-13 Receptor Alpha 2 (il13ra2) Chimeric Antigen Receptor for Tumor Specific T Cell Immunotherapy
0 cites
US11959073utility2024
Coupling Endonucleases with End-processing Enzymes Drives High Efficiency Gene Disruption
0 cites
US11873479utility2024
Coupling Endonucleases with End-processing Enzymes Drives High Efficiency Gene Disruption
0 cites